Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
1.580
-0.120 (-7.06%)
At close: Mar 28, 2025, 4:00 PM
1.616
+0.036 (2.27%)
After-hours: Mar 28, 2025, 7:56 PM EDT
Longeveron Revenue
In the year 2024, Longeveron had annual revenue of $2.39M with 237.38% growth. Longeveron had revenue of $603.00K in the quarter ending December 31, 2024, with 857.14% growth.
Revenue (ttm)
$2.39M
Revenue Growth
+237.38%
P/S Ratio
6.22
Revenue / Employee
$95,680
Employees
25
Market Cap
23.59M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
LGVN News
- 19 days ago - Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer's Disease - GlobeNewsWire
- 25 days ago - Longeveron® to Present at the 37th Annual Roth Conference - GlobeNewsWire
- 4 weeks ago - Longeveron Inc. (LGVN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™ - GlobeNewsWire
- 3 months ago - Longeveron to Present at Biotech Showcase 2025 - GlobeNewsWire
- 4 months ago - Longeveron to Present at the Emerging Growth Virtual Conference on December 5, 2024 - GlobeNewsWire
- 4 months ago - Longeveron, Inc. (LGVN) Q3 2024 Earnings Call Transcript - Seeking Alpha